Helicobacter pylori – Therapy and Use of Medicinal Plants

*Helicobacter pylori* is a gram-negative, helical-shaped bacterium whose primary ecological niche is the human gastrointestinal tract. While initial references to this microorganism emerged in late 19th-century medical literature, its direct isolation from the gastric mucosa of patients with ulcerative lesions was not achieved until 1982, thanks to the groundbreaking research conducted by Barry Marshall and Robin Warren. Contemporary epidemiological estimates suggest that *H. pylori* colonizes the digestive systems of up to 50% of the global population, though only 10–20% of infected individuals develop symptomatic conditions attributable to its presence. The highest prevalence rates are documented in low-income regions where suboptimal sanitary conditions and personal hygiene practices prevail. Transmission occurs predominantly via fecal–oral or oral–oral routes, frequently during early childhood. Owing to its capacity to secrete urease, *H. pylori* effectively neutralizes the acidic gastric environment, thereby facilitating its survival and proliferation within the mucus layer overlaying the gastric epithelium. Initially, the bacterium colonizes the pyloric antrum—the anatomical junction between the esophagus and stomach—before progressively spreading across the entire mucosal surface and occasionally reaching the proximal duodenum. Chronic infection with this pathogen constitutes the primary risk factor for the development of type B gastritis, peptic ulcer disease (affecting both the stomach and duodenum), and—over prolonged periods—gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma.

To treat only confirmed infections of H. pylori. However, in the case of diseases caused by this bacterium, the pharmacological significance of this treatment is crucial, although it does not contain the appropriate antibiotics and tooth decongestant agents, as this also increases the chances of complete elimination of the bacterial infection of the stomach. Treatment lasts about 7 days and is currently considered the most important treatment for the eradication of H.. pylori infection. In case of infections caused by the bacterium Socoto, however, it is important that the treatment of these antibiotics, which do not contain any poisonous agents of the tooth sour juice, is also effective. In this way, treatment of certain bacteria and herbal infections can also be supplemented by the proper effects of antibiotics.

Infection with *Helicobacter pylori* often necessitates a multifaceted therapeutic approach in which carefully selected medicinal herbs with documented antimicrobial properties can play a significant role. Botanical materials contain a diverse array of bioactive compounds—ranging from polyphenols and glycosides to essential oils—whose efficacy has been substantiated through *in vitro* and *in vivo* research. The systematic administration of appropriately formulated herbal preparations may not only accelerate pathogen eradication but also fortify the gastric mucosal barrier, thereby diminishing the likelihood of disease recurrence. It is crucial to emphasize, however, that herbal medicine should serve as a *complement* to, rather than a *replacement* for, the antibiotic regimens prescribed by healthcare professionals. Prior to integrating any dietary supplements into the treatment protocol, consultation with the attending physician is indispensable due to potential interactions between phytochemical constituents and synthetic active pharmaceutical ingredients.